Eddy Lee is an accomplished drug development and manufacturing leader, currently serving as SVP of Technical Operations at Structure Therapeutics since 2025. With over 30 years of experience in the biopharmaceutical industry, Eddy has held significant roles, including SVP CMC at Turning Point Therapeutics and Vice President CMC at Biota Pharmaceuticals, where they led critical initiatives for novel therapies targeting serious viral infections. Eddy began their career at Genzyme, where they advanced through various roles, contributing to significant progress in treating unmet medical needs. They hold a PhD in Organic Chemistry from the University of Warwick and completed post-doctoral studies at the University of Bern.
This person is not in any teams
This person is not in any offices